PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ATXI vs. CRON
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


ATXICRON
YTD Return-84.43%-0.96%
1Y Return-86.81%6.15%
3Y Return (Ann)-89.38%-29.69%
5Y Return (Ann)-80.53%-19.95%
Sharpe Ratio-0.610.07
Sortino Ratio-1.310.52
Omega Ratio0.821.06
Calmar Ratio-0.870.04
Martin Ratio-1.190.19
Ulcer Index73.46%18.22%
Daily Std Dev143.42%52.51%
Max Drawdown-99.99%-92.95%
Current Drawdown-99.99%-91.27%

Fundamentals


ATXICRON
Market Cap$2.91M$863.96M
EPS$37.48-$0.15
Total Revenue (TTM)$0.00$77.51M
EBITDA (TTM)-$8.65M-$43.07M

Correlation

-0.50.00.51.00.1

The correlation between ATXI and CRON is 0.12, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

ATXI vs. CRON - Performance Comparison

In the year-to-date period, ATXI achieves a -84.43% return, which is significantly lower than CRON's -0.96% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-50.00%
-31.46%
ATXI
CRON

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ATXI vs. CRON - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Avenue Therapeutics, Inc. (ATXI) and Cronos Group Inc. (CRON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ATXI
Sharpe ratio
The chart of Sharpe ratio for ATXI, currently valued at -0.61, compared to the broader market-4.00-2.000.002.004.00-0.61
Sortino ratio
The chart of Sortino ratio for ATXI, currently valued at -1.31, compared to the broader market-4.00-2.000.002.004.006.00-1.31
Omega ratio
The chart of Omega ratio for ATXI, currently valued at 0.82, compared to the broader market0.501.001.502.000.82
Calmar ratio
The chart of Calmar ratio for ATXI, currently valued at -0.87, compared to the broader market0.002.004.006.00-0.87
Martin ratio
The chart of Martin ratio for ATXI, currently valued at -1.19, compared to the broader market0.0010.0020.0030.00-1.19
CRON
Sharpe ratio
The chart of Sharpe ratio for CRON, currently valued at 0.07, compared to the broader market-4.00-2.000.002.004.000.07
Sortino ratio
The chart of Sortino ratio for CRON, currently valued at 0.52, compared to the broader market-4.00-2.000.002.004.006.000.52
Omega ratio
The chart of Omega ratio for CRON, currently valued at 1.06, compared to the broader market0.501.001.502.001.06
Calmar ratio
The chart of Calmar ratio for CRON, currently valued at 0.04, compared to the broader market0.002.004.006.000.04
Martin ratio
The chart of Martin ratio for CRON, currently valued at 0.19, compared to the broader market0.0010.0020.0030.000.19

ATXI vs. CRON - Sharpe Ratio Comparison

The current ATXI Sharpe Ratio is -0.61, which is lower than the CRON Sharpe Ratio of 0.07. The chart below compares the historical Sharpe Ratios of ATXI and CRON, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00JuneJulyAugustSeptemberOctoberNovember
-0.61
0.07
ATXI
CRON

Dividends

ATXI vs. CRON - Dividend Comparison

Neither ATXI nor CRON has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ATXI vs. CRON - Drawdown Comparison

The maximum ATXI drawdown since its inception was -99.99%, which is greater than CRON's maximum drawdown of -92.95%. Use the drawdown chart below to compare losses from any high point for ATXI and CRON. For additional features, visit the drawdowns tool.


-100.00%-98.00%-96.00%-94.00%-92.00%-90.00%-88.00%JuneJulyAugustSeptemberOctoberNovember
-99.99%
-91.27%
ATXI
CRON

Volatility

ATXI vs. CRON - Volatility Comparison

Avenue Therapeutics, Inc. (ATXI) has a higher volatility of 25.18% compared to Cronos Group Inc. (CRON) at 20.66%. This indicates that ATXI's price experiences larger fluctuations and is considered to be riskier than CRON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%20.00%30.00%40.00%50.00%60.00%JuneJulyAugustSeptemberOctoberNovember
25.18%
20.66%
ATXI
CRON

Financials

ATXI vs. CRON - Financials Comparison

This section allows you to compare key financial metrics between Avenue Therapeutics, Inc. and Cronos Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items